This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of breast, other/unspecified
CD2_INSITU_BREAST_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of breast, other/unspecified
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 471 | 471 | - |
| Unadjusted period prevalence (%) | 0.16 | 0.16 | - |
| Median age at first event (years) | 58.47 | 58.47 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 414
- Matched controls
- 4140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
+∞
323.0
301
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
5230.1
258.6
222
*
PJA12
NOMESCO Finland
Sentinel node biopsy
1094.5
206.4
185
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
173.5
154
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
172.2
153
*
HAC20
NOMESCO Finland
Total mastectomy
2103.1
154.3
140
*
115
Kela drug reimbursment
Breast cancer
+∞
154.0
138
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
212.5
152.4
150
11
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
116.3
106
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
111.6
102
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
103.6
95
*
HA1AA
NOMESCO Finland
X-ray mammography
26.7
96.4
137
75
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
37.5
92.6
119
44
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
80.9
75
*
L02BG04
ATC
letrozole; oral
309.1
77.3
76
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
865.8
75.7
72
*
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
+∞
75.3
70
*
H02AB02
ATC
dexamethasone; systemic
66.5
74.5
85
16
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
70.9
66
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
68.7
64
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
765.7
68.0
65
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
66.5
62
*
L02BA01
ATC
tamoxifen; oral
+∞
63.2
59
*
TQW20
NOMESCO Finland
Tatoe
+∞
59.9
56
*
A04AA02
ATC
granisetron; systemic, transdermal
655.9
59.2
57
*
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
+∞
57.7
54
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
41.2
43.4
54
15
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
41.3
39
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.1
41.1
157
442
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
40.3
38
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
39.2
37
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
+∞
38.1
36
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
36.0
34
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
36.0
34
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
34.9
33
*
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
+∞
34.9
33
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.9
34.4
72
86
HAB99
NOMESCO Finland
Other partial excision of mammary gland
35.0
34.3
44
14
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
61.2
33.9
39
7
ZZR10
NOMESCO Finland
Flap of skin and muscle
+∞
33.8
32
*
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
15.2
33.4
56
42
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
32.7
31
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
32.7
31
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
32.7
31
*
D05.0
ICD-10 Finland
Lobular carcinoma in situ
+∞
31.7
30
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
31.7
30
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
31.7
30
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
29.8
123
357
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
29.7
177
710
X76
ICPC
Malignant neoplasm breast female
+∞
29.5
28
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
29.5
28
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
28.5
27
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
28.5
27
*
Z31.5
ICD-10 Finland
Genetic counselling
11.0
28.2
55
57
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
149.7
27.0
28
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
26.3
25
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
53.7
25.6
30
6
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
25.3
24
*
N63
ICD-10 Finland
Unspecified lump in breast
6.8
24.9
66
113
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
24.2
23
*
9703
FHL
Breast resection
33.4
24.1
31
10
HAE99
NOMESCO Finland
Other reconstruction of breast
132.7
23.9
25
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
132.7
23.9
25
*
JN4BD
NOMESCO Finland
Extensive body CT
7.9
23.9
56
80
A04AD12
ATC
aprepitant; systemic
242.8
22.9
23
*
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
47.9
22.6
27
6
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
22.1
21
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
231.7
21.8
22
*
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
7.8
21.7
51
73
NK6AN
NOMESCO Finland
Total body bone isotope imaging
81.1
20.9
23
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
57.9
19.1
22
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
36.3
19.1
24
7
L02BG06
ATC
exemestane; oral
+∞
18.9
18
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
18.9
18
*
130
Kela drug reimbursment
Malignant tumour
+∞
18.9
18
*
HAD99
NOMESCO Finland
Other plastic operation on breast
73.4
18.9
21
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
73.4
18.9
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
198.6
18.7
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.3
18.3
33
29
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
69.8
17.9
20
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
19.7
17.5
26
14
WX702
NOMESCO Finland
Supraglottic ventilation device
5.3
16.9
53
111
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
16.8
16
*
L02BG03
ATC
anastrozole; oral
+∞
16.8
16
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
176.8
16.6
17
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
15.7
15
*
D05
ICD-10 Finland
Carcinoma in situ of breast
+∞
15.7
15
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
15.7
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.7
15
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
166.0
15.6
16
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
14.7
14
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
14.7
14
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
14.7
14
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
155.2
14.6
15
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
155.2
14.6
15
*
5702
FHL
Local lymph node removal (eg armpit, groin)
155.2
14.6
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
155.2
14.6
15
*
TQB05
NOMESCO Finland
Puncture of skin of trunk
44.1
14.2
17
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
13.6
13
*
9706
FHL
Ablation mammae, includes axillary exploration
+∞
13.6
13
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
13.6
13
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
144.5
13.5
14
*
WX402
NOMESCO Finland
General anaesthesia
3.1
13.0
80
300
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
12.6
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
12.4
47
121
HAD40
NOMESCO Finland
Mastopexy
38.8
12.3
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
31.0
11.7
15
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
11.7
189
1179
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
11.5
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
10.9
116
593
9702
FHL
Breast exploration and possible tumor removal
7.0
10.9
26
39
QBA00
NOMESCO Finland
Puncture of skin of trunk
61.6
10.7
12
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
112.7
10.5
11
*
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
10.5
10
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.5
10
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
10.5
10
*
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
33.5
10.4
13
*
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
7.5
10.1
23
32
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.7
10.1
34
78
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
26.7
9.9
13
5
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
102.3
9.5
10
*
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
+∞
9.4
9
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
9.4
9
*
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
+∞
9.4
9
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
9.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
9.4
9
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.5
9.2
23
37
HAA10
NOMESCO Finland
Biopsy of mammary gland
10.4
9.1
17
17
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
37.6
9.1
11
*
TQW99
NOMESCO Finland
Other minor procedure on skin
5.1
8.8
27
56
WZC30
NOMESCO Finland
Teaching
3.0
8.7
53
196
JN4CD
NOMESCO Finland
Very extensive body CT
9.3
8.6
17
19
HA1AE
SPAT
NA
7.6
8.5
19
26
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
28.2
8.5
11
*
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
28.2
8.5
11
*
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
91.8
8.4
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
91.8
8.4
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
91.8
8.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
PJ5YQ
NOMESCO Finland
NA
+∞
8.4
8
*
HAD20
NOMESCO Finland
Liposuction of breast
+∞
8.4
8
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.4
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.4
8
*
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
34.1
8.1
10
*
WF002
NOMESCO Finland
Radical radiotherapy
45.8
7.7
9
*
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
25.5
7.6
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
81.5
7.4
8
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
7.3
7
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
7.3
7
*
HA1SA
NOMESCO Finland
Expansion mammography
+∞
7.3
7
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
7.3
7
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
20.4
7.2
10
5
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
40.7
6.8
8
*
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
40.7
6.8
8
*
D24
ICD-10 Finland
Benign neoplasm of breast
5.3
6.7
19
37
X21
ICPC
Breast sympt/compl female other
6.1
6.7
17
29
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.5
6.6
11
9
HA1AA
SPAT
NA
5.2
6.6
19
38
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
6.5
26
72
9719
FHL
Other measure in this category
70.9
6.4
7
*
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
14.6
6.4
10
7
ZXA05
NOMESCO Finland
Left side
1.8
6.4
121
761
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
394
Kela drug reimbursment
Palbociclib
+∞
6.3
6
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
1501
Kela drug reimbursment
Palbociclib
+∞
6.3
6
*
L01XE33
ATC
[U] palbociclib; oral
+∞
6.3
6
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
6.3
6
*
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
+∞
6.3
6
*
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
+∞
6.3
6
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.3
6
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
A04AA01
ATC
ondansetron; systemic, rectal
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
234
1364
2.42
19.58
3.6
2.1
2.4
2.4
mmol/l
0.26
216
1132
71
224
3.55
19.08
5.0
1.4
4.3
2.6
ug/l
1.42
60
176
24
7
36.01
19.07
4.9
1.0
31.0
17.6
u/ml
—
24
7
390
3014
2.71
15.43
9.1
5.2
73.8
76.0
u/l
0.92
362
2763
92
382
2.75
15.31
3.1
3.1
—
—
—
0
0
276
1870
2.15
14.52
7.2
3.3
9.5
10.6
umol/l
1.39
257
1739
79
317
2.79
13.97
4.1
2.6
1.2
1.2
mmol/l
0.43
62
257
239
1654
1.90
10.58
3.6
3.4
—
—
—
0
0
24
60
4.16
8.89
1.4
1.3
—
—
—
0
0
279
2115
1.78
8.44
10.0
6.5
3.5
4.1
e9/l
6.23
258
1833
49
214
2.44
7.21
2.1
1.5
22.0
21.6
u/ml
0.02
44
204
10
5
20.38
7.16
1.1
1.2
—
—
—
0
0
241
1827
1.65
6.66
5.0
4.4
1.2
1.2
mmol/l
0.05
208
1605
88
537
1.79
5.28
2.4
2.2
0.8
0.8
mmol/l
0.36
80
490
253
2023
1.54
5.04
5.9
4.9
1.2
1.2
mmol/l
0.70
183
1715
23
95
2.49
3.86
3.4
1.8
241.8
77.5
u/ml
0.33
18
81
49
281
1.83
3.60
2.0
1.8
0.2
0.2
g/l
1.52
42
264
363
3252
1.51
3.44
19.0
14.7
13.6
13.7
%
0.28
351
3166
112
809
1.50
3.35
2.8
2.2
2.5
2.5
mmol/l
0.02
106
699
143
1821
0.69
3.32
2.0
2.0
99.5
99.3
pmol/l
0.02
67
828
417
3867
1.68
3.26
16.0
11.0
77.8
76.4
ml/min/173m2
0.89
369
3080
57
355
1.69
3.17
2.8
1.9
5.7
5.2
umol/l
0.16
43
305
106
1410
0.68
3.06
3.9
3.7
10.4
6.7
mg/mmol
0.30
51
782
111
818
1.47
2.99
2.1
1.9
—
—
—
0
0
17
73
2.38
2.68
2.8
2.3
16.6
16.4
%
0.07
12
33
383
3535
1.45
2.52
16.3
13.8
39.4
38.9
%
0.68
250
2337
198
1660
1.33
2.40
4.3
3.3
36.3
35.8
g/l
0.71
179
1529
36
571
0.60
2.30
4.7
6.6
—
—
—
0
0
371
3950
0.71
2.25
5.1
6.0
39.2
39.9
mmol/mol
0.92
310
3633
8
24
3.37
2.19
5.9
1.5
3.1
3.2
nmol/l
—
8
24
10
38
2.67
2.02
1.2
1.1
0.1
3.2
u/ml
—
5
12
15
72
2.12
1.88
2.3
2.9
4.3
4.3
e9/l
0.02
15
72
0
53
0.00
1.88
0.0
1.0
—
—
—
0
0
15
73
2.09
1.82
2.9
3.2
59.5
59.9
%
0.03
15
73
11
228
0.47
1.73
2.5
2.4
127.5
127.4
g/l
0.01
11
218
21
118
1.82
1.73
1.4
1.2
38.8
33.9
iu/l
0.28
21
105
7
24
2.94
1.73
1.4
1.4
—
—
—
0
0
108
867
1.32
1.71
1.5
1.4
—
—
—
0
0
14
264
0.52
1.68
2.2
2.3
3.6
4.6
kpa
2.75
14
255
19
323
0.57
1.62
2.4
2.9
6.2
5.9
kpa
1.12
19
313
8
32
2.53
1.60
1.4
1.4
—
—
—
0
0
5
15
3.36
1.52
1.2
1.2
—
—
—
0
0
36
246
1.50
1.45
1.4
1.5
—
—
—
0
0
5
16
3.15
1.44
1.4
1.2
—
—
—
0
0
5
16
3.15
1.44
1.4
1.2
—
—
—
0
0
408
4229
0.74
1.40
5.2
5.4
2.9
2.8
mmol/l
1.52
332
3863
8
161
0.49
1.38
1.6
1.5
—
—
—
0
0
136
1159
1.24
1.33
3.3
2.4
27.8
29.9
u/l
0.46
131
1103
6
131
0.45
1.30
2.3
2.0
897.2
1791.6
ug/l
—
6
118
10
48
2.11
1.28
1.3
1.3
—
—
—
0
0
72
569
1.31
1.28
1.8
1.8
—
—
—
0
0
72
569
1.31
1.28
2.1
2.7
2.4
4.5
e6/l
1.50
37
287
16
92
1.77
1.26
1.7
2.8
—
—
—
0
0
32
221
1.48
1.25
1.9
1.7
—
—
—
0
0
399
4138
0.77
1.24
4.6
4.9
5.8
5.9
mmol/l
0.57
315
3754
68
849
0.77
1.22
2.0
1.7
1197.5
1213.9
nmol/l
0.04
41
627
213
1917
1.20
1.19
2.3
2.3
81.8
81.3
nmol/l
0.10
184
1686
53
405
1.35
1.19
1.7
1.8
—
—
—
0
0
23
343
0.65
1.19
3.3
2.1
64.2
65.7
ml/min/173m2
—
8
138
59
460
1.32
1.16
3.2
3.4
1.0
1.0
mmol/l
0.23
52
407
44
328
1.38
1.16
2.3
1.4
68.8
67.6
g/l
0.45
38
293
5
20
2.52
1.15
1.4
1.2
—
—
—
0
0
380
3957
0.79
1.15
3.9
4.3
1.2
1.3
mmol/l
0.94
304
3562
45
338
1.37
1.13
2.2
1.9
29.4
36.2
u/l
0.83
37
273
26
178
1.49
1.08
3.8
6.1
24.4
25.5
mmol/l
0.67
26
178
401
4143
0.78
1.06
4.5
4.8
4.9
4.8
mmol/l
0.79
327
3802
13
75
1.75
1.03
1.1
1.2
—
—
—
0
0
117
1348
0.82
1.03
2.0
2.1
138.0
160.4
u/l
0.36
106
1278
86
1021
0.81
1.02
1.5
1.6
19.4
22.5
nmol/l
1.22
68
863
52
407
1.31
1.02
1.7
1.8
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
11
61
1.82
0.99
1.3
1.2
—
—
—
0
0
11
61
1.82
0.99
1.4
1.4
—
—
—
0
0
26
182
1.45
0.98
1.1
1.3
—
—
—
0
0
45
575
0.76
0.98
5.1
4.9
35.0
34.1
%
0.24
27
366
398
4107
0.80
0.95
4.5
4.8
1.6
1.6
mmol/l
0.96
323
3747
13
79
1.66
0.89
2.6
3.1
23.9
26.1
mmol/l
1.69
13
70
20
286
0.69
0.87
3.5
4.6
1.2
1.4
mmol/l
0.88
20
276
8
43
1.87
0.87
1.4
1.4
—
—
—
0
0
11
179
0.61
0.86
2.5
2.5
26.0
25.7
mmol/l
0.16
11
171
256
2386
1.16
0.86
2.9
2.8
45.1
41.8
u/l
0.25
222
2180
85
990
0.83
0.84
2.2
2.2
2.6
3.0
mg/l
1.04
66
832
155
1713
0.86
0.83
2.5
2.6
110.4
93.6
ug/l
0.79
131
1556
329
3130
1.17
0.83
3.9
4.4
13.6
12.9
mm/h
0.32
284
2875
61
505
1.24
0.79
22.5
23.9
1.4
1.3
inr
—
6
73
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
11
66
1.68
0.79
1.4
1.4
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
435
4252
1.30
0.78
15.8
14.2
139.9
139.9
mmol/l
0.00
413
4134
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
84
1.56
0.72
4.3
2.4
0.3
0.4
u/ml
—
8
56
11
68
1.63
0.72
2.8
2.0
3.4
3.3
g/l
0.05
11
63
5
26
1.93
0.71
1.0
1.6
—
—
—
0
0
73
626
1.20
0.69
2.1
2.5
1.1
1.6
e6/l
0.86
38
345
7
42
1.68
0.68
1.4
1.2
—
—
—
0
0
435
4262
1.27
0.67
16.0
14.3
3.9
3.9
mmol/l
0.32
410
4134
7
43
1.64
0.67
1.1
1.1
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
24
313
0.75
0.64
1.2
1.2
92.5
145.1
iu/ml
—
6
130
113
1013
1.15
0.63
2.7
3.0
0.5
0.4
e6/l
0.17
79
777
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
2.2
—
41.2
—
0
20
10
150
0.66
0.59
1.4
1.7
2.5
2.2
mg/l
—
10
109
6
35
1.72
0.58
2.0
1.6
4.3
109.1
u/ml
—
6
35
6
37
1.63
0.55
1.5
1.2
—
—
—
0
0
70
796
0.86
0.54
3.4
4.0
281.1
363.5
ng/l
0.12
53
619
6
39
1.55
0.53
6.8
1.8
81.5
15.8
u/ml
—
6
39
6
39
1.55
0.53
1.5
1.2
—
—
—
0
0
13
180
0.71
0.52
1.1
1.5
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
47
1.50
0.47
1.6
1.3
—
—
—
0
0
7
49
1.43
0.46
1.3
1.4
—
—
—
0
0
87
960
0.89
0.45
1.6
1.7
464.2
24084227.0
pmol/l
1.06
56
764
406
3979
1.15
0.45
14.9
12.0
18.6
19.8
mg/l
0.39
318
3041
72
802
0.88
0.43
1.3
1.3
23.2
13.2
u/ml
0.30
25
307
390
3979
0.88
0.43
5.4
5.5
1.8
2.2
mu/l
0.68
328
3624
5
32
1.57
0.42
1.2
1.3
—
55.5
u/l
—
0
11
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
96
877
1.12
0.42
1.5
1.6
1.5
1.0
mg/l
0.27
74
668
23
282
0.81
0.41
1.7
1.7
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
217.1
—
0
16
438
4321
1.19
0.41
12.5
9.1
24.8
22.9
u/l
0.51
410
4134
16
123
1.31
0.41
2.2
1.3
0.0
0.0
g/l
0.00
16
114
436
4300
1.19
0.41
18.3
14.0
69.5
70.7
umol/l
0.66
436
4300
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
32
270
1.20
0.39
1.3
1.3
—
52.2
—
0
12
16
124
1.30
0.39
2.2
1.3
0.0
0.0
g/l
0.00
16
115
0
19
0.00
0.39
0.0
1.2
—
9.8
—
0
19
5
76
0.65
0.36
1.4
1.2
0.5
0.7
nmol/l
—
5
71
5
80
0.62
0.35
2.0
1.4
—
—
—
0
0
16
128
1.26
0.32
2.2
1.4
0.0
0.0
g/l
0.50
16
118
7
99
0.70
0.31
1.6
1.4
—
—
—
0
0
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
56
508
1.12
0.29
2.1
2.3
2.2
2.4
g/l
2.68
45
468
51
460
1.12
0.29
2.1
2.4
22.3
22.0
%
0.04
41
387
17
205
0.82
0.28
1.1
1.1
—
—
—
0
0
12
94
1.28
0.28
1.8
1.6
—
—
—
0
0
20
168
1.20
0.27
2.0
1.4
—
—
—
0
0
115
1087
1.08
0.26
3.8
4.4
0.0
0.0
estimate
0.00
48
343
213
2201
0.94
0.25
2.8
2.6
—
—
—
0
0
447
4436
1.15
0.23
22.6
18.3
130.8
132.5
g/l
2.14
431
4359
21
182
1.16
0.21
2.8
3.1
1.5
2.3
mmol/l
0.56
14
139
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
1.8
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
8
103
0.77
0.21
1.9
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.3
—
0
8
10
80
1.26
0.20
1.4
1.9
143.7
182.5
%
—
10
74
128
1226
1.06
0.20
1.6
1.7
1.3
1.3
mmol/l
0.36
81
1019
13
154
0.84
0.19
1.0
1.4
—
—
—
0
0
24
214
1.13
0.18
1.4
1.5
—
—
—
0
0
41
378
1.09
0.17
2.2
3.1
63.8
79.6
ng/l
0.98
29
329
76
800
0.94
0.16
1.2
1.3
55.8
41.3
iu/ml
0.16
18
268
208
2029
1.05
0.16
3.5
4.1
0.0
0.0
estimate
0.00
48
346
8
69
1.16
0.16
1.0
1.2
—
—
—
0
0
8
100
0.80
0.13
1.4
1.1
—
—
—
0
0
18
201
0.89
0.13
1.2
1.3
—
—
—
0
0
92
954
0.96
0.12
2.2
2.1
316.2
5562.2
umol/l
3.66
72
800
128
1246
1.04
0.11
1.8
2.1
50.4
59.6
u/l
2.30
107
1122
232
2284
1.03
0.10
3.8
3.7
6.4
6.7
mmol/l
1.56
223
2120
15
135
1.11
0.10
1.1
1.3
—
2.5
—
0
17
352
3490
1.03
0.09
4.6
4.5
15.2
14.9
pmol/l
1.04
290
3180
17
155
1.10
0.09
1.6
1.9
—
—
—
0
0
58
559
1.04
0.08
2.3
2.3
12.3
13.1
umol/l
0.36
49
511
14
127
1.11
0.08
1.9
1.7
—
—
—
0
0
154
1567
0.97
0.08
3.9
4.3
—
—
—
0
0
208
2052
1.02
0.07
4.7
5.4
0.0
0.0
estimate
0.00
47
337
6
70
0.86
0.07
1.2
1.5
—
—
—
0
0
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
8
77
1.04
0.07
1.8
1.7
—
—
—
0
0
11
122
0.90
0.07
1.6
1.7
—
—
—
0
0
9
103
0.87
0.06
1.0
1.1
—
—
—
0
0
135
1329
1.02
0.06
2.7
3.1
—
—
—
0
0
28
267
1.05
0.05
1.2
1.2
117.5
181.4
u/ml
0.77
23
244
208
2060
1.02
0.05
3.6
4.1
0.0
0.0
estimate
0.80
47
341
11
120
0.91
0.05
2.3
1.4
—
—
—
0
0
14
130
1.08
0.04
1.1
1.2
—
—
—
0
0
14
130
1.08
0.04
1.1
1.2
—
—
—
0
0
30
292
1.03
0.02
1.6
1.5
1.2
1.3
%
0.59
24
256
13
137
0.95
0.01
1.5
1.7
—
120.0
—
0
8
61
617
0.99
0.01
1.4
1.4
—
—
—
0
0
37
376
0.98
0.00
1.8
1.8
370.7
360.1
nmol/l
0.11
32
340
127
1276
0.99
0.00
2.5
2.7
1015.8
1124.0
ng/l
0.21
104
1061
26
257
1.01
0.00
2.1
2.8
4.6
4.5
pmol/l
0.23
18
218
12
122
0.98
0.00
2.0
1.6
—
—
—
0
0
11
109
1.01
0.00
1.1
1.3
—
10.3
—
0
10
18
179
1.01
0.00
1.4
2.4
0.2
0.2
e6/l
0.04
18
172
39
391
1.00
0.00
4.7
5.3
2.0
1.6
mmol/l
0.45
30
313
93
933
1.00
0.00
1.2
1.3
0.6
2.3
u/ml
2.07
22
243
157
1575
1.00
0.00
3.5
3.6
29.1
90.9
ng/l
0.71
117
1080
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
62
0.97
0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
0.7
—
0
7
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
101.7
—
0
7
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
11.2
—
0
5
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
59.0
—
0
5
0
8
0.00
0.00
0.0
2.5
—
1.2
—
0
8
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_NOS_EXALLC – Carcinoma in situ of breast, other/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).